Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
Molecular and Clinical Oncology|October 6, 2016
Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: A case reportRaita Fukaya, Masatoki Ozaki, Dai Kamamoto, et al.The American Journal of Pathology|April 17, 2010
RECK is up-regulated and involved in chondrocyte cloning in human osteoarthritic cartilageTokuhiro Kimura, Aiko Okada, Taku Yatabe, et al.Journal of Neuropathology and Experimental Neurology|August 23, 2013
Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosisYohei Kitamura, Hikaru Sasaki, Tokuhiro Kimura, et al.Plos One|January 23, 2016
Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in GlioblastomaAya Ishii, Tokuhiro Kimura, Hirokazu Sadahiro, et al.Scientific Reports|December 6, 2016
Basigin can be a therapeutic target to restore the retinal vascular barrier function in the mouse model of diabetic retinopathyMitsuru Arima, Dan Cui, Tokuhiro Kimura, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shockKeisuke Horiuchi, Tokuhiro Kimura, Takeshi Miyamoto, et al.Pediatric Research|February 17, 2009
Caudal regression and tracheoesophageal malformation induced by adriamycin: a novel chick model of VATER associationYoko Naito, Tokuhiro Kimura, Michihiko Aramaki, et al.Bone|February 17, 2020
ADAM10 is indispensable for longitudinal bone growth in miceSakiko Mizuno, Masaki Yoda, Tokuhiro Kimura, et al.Plos One|January 24, 2013
Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivoMasaki Yoda, Tokuhiro Kimura, Takahide Tohmonda, et al.BMJ Open|November 25, 2021
Vasohibin-1 expression as a biomarker of aggressive nature in ductal adenocarcinoma of the prostate: a retrospective cohort study at two centres in JapanHiroaki Kobayashi, Takeo Kosaka, Shuji Mikami, et al.Pageof 8